X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Abbott India - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ABBOTT INDIA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ABBOTT INDIA FULFORD INDIA/
ABBOTT INDIA
 
P/E (TTM) x 398.8 32.8 1,214.5% View Chart
P/BV x 6.2 8.2 75.8% View Chart
Dividend Yield % 0.1 0.8 10.3%  

Financials

 FULFORD INDIA   ABBOTT INDIA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ABBOTT INDIA
Mar-16
FULFORD INDIA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs9426,015 15.7%   
Low Rs4503,707 12.1%   
Sales per share (Unadj.) Rs691.41,236.9 55.9%  
Earnings per share (Unadj.) Rs11.5122.2 9.4%  
Cash flow per share (Unadj.) Rs15.4129.0 11.9%  
Dividends per share (Unadj.) Rs2.0035.00 5.7%  
Dividend yield (eoy) %0.30.7 39.9%  
Book value per share (Unadj.) Rs380.0521.2 72.9%  
Shares outstanding (eoy) m3.9021.25 18.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.9 25.6%   
Avg P/E ratio x60.739.8 152.6%  
P/CF ratio (eoy) x45.337.7 120.2%  
Price / Book Value ratio x1.89.3 19.6%  
Dividend payout %17.428.6 60.9%   
Avg Mkt Cap Rs m2,714103,296 2.6%   
No. of employees `0000.43.0 15.0%   
Total wages/salary Rs m5053,370 15.0%   
Avg. sales/employee Rs Th6,073.08,891.8 68.3%   
Avg. wages/employee Rs Th1,137.41,140.0 99.8%   
Avg. net profit/employee Rs Th100.7878.3 11.5%   
INCOME DATA
Net Sales Rs m2,69626,284 10.3%  
Other income Rs m125504 24.9%   
Total revenues Rs m2,82226,789 10.5%   
Gross profit Rs m-463,665 -1.3%  
Depreciation Rs m15144 10.5%   
Interest Rs m108 117.3%   
Profit before tax Rs m544,017 1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m101,421 0.7%   
Profit after tax Rs m452,596 1.7%  
Gross profit margin %-1.713.9 -12.3%  
Effective tax rate %17.735.4 50.0%   
Net profit margin %1.79.9 16.8%  
BALANCE SHEET DATA
Current assets Rs m1,73814,446 12.0%   
Current liabilities Rs m5454,725 11.5%   
Net working cap to sales %44.337.0 119.7%  
Current ratio x3.23.1 104.4%  
Inventory Days Days4851 94.3%  
Debtors Days Days420 22.0%  
Net fixed assets Rs m121,113 1.1%   
Share capital Rs m39213 18.4%   
"Free" reserves Rs m1,44310,808 13.4%   
Net worth Rs m1,48211,076 13.4%   
Long term debt Rs m00-   
Total assets Rs m2,07716,241 12.8%  
Interest coverage x6.7497.0 1.4%   
Debt to equity ratio x00-  
Sales to assets ratio x1.31.6 80.2%   
Return on assets %2.616.0 16.3%  
Return on equity %3.023.4 12.9%  
Return on capital %4.336.3 11.8%  
Exports to sales %00.6 0.0%   
Imports to sales %24.512.6 193.4%   
Exports (fob) Rs mNA162 0.0%   
Imports (cif) Rs m6593,322 19.8%   
Fx inflow Rs m17268 6.4%   
Fx outflow Rs m6733,927 17.1%   
Net fx Rs m-656-3,659 17.9%   
CASH FLOW
From Operations Rs m902,514 3.6%  
From Investments Rs m105-800 -13.1%  
From Financial Activity Rs m-14-803 1.8%  
Net Cashflow Rs m181912 19.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 75.0 100.0%  
Indian inst/Mut Fund % 3.8 7.9 48.1%  
FIIs % 0.1 0.1 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 17.1 124.0%  
Shareholders   4,783 18,270 26.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   PIRAMAL ENTERPRISES  NOVARTIS  PANACEA BIOTECH  DR. REDDYS LAB  GSK PHARMA  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS